non-small cell lung cancer
OncoHost, Heidelberg University Hospital Strike Lung Cancer Biomarker Alliance
The partners will collect and analyze blood samples to identify novel biomarkers and therapeutic targets, primarily for non-small cell lung cancer.
FDA Approves Thermo Fisher Scientific Oncomine Dx Assay as CDx for Janssen Lung Cancer Drug
The Oncomine Dx Target Test will be used as a companion diagnostic to identify NSCLC patients whose tumors carry EGFR Exon20-insertion mutations.
Postsurgical ctDNA Analysis Predicts Adjuvant Chemotherapy Benefit in NSCLC
Research out of Geneseeq and the Chinese Academy of Medical Sciences shows the value of ctDNA analysis to guide treatment and predict disease recurrence.
The company recently presented new results on the test's sensitivity and specificity, as well as its performance across specific nodule sizes and cancer stages.
Lung Cancer Treatment Response Linked to Cancer-Associated Fibroblast Cell Subtypes
Starting from NSCLC tumor samples, researchers identified three cancer-associated fibroblast subtypes with distinct molecular and treatment response features.